What is the ocular phenotype associated with a single exon 78 deletion in Duchenne muscular dystrophy?

被引:0
|
作者
Tuy Nga Brignol
Dominique Mornet
Cecilia Montañez
Dora Fix Ventura
Cyrille Vaillend
Alvaro Rendón
机构
[1] The French Muscular Dystrophy,Medical Affairs Department
[2] Association (AFM-Telethon),PhyMedExp
[3] Université de Montpellier,Departamento de Genética y Biología Molecular
[4] INSERM,Department of Experimental Psychology, Institute of Psychology
[5] CNRS,Paris
[6] Centro de Investigación y de Estudios Avanzados del IPN,Saclay Institute of Neuroscience, UMR 9197, Université Paris Sud, CNRS
[7] Ciudad de,Sorbonne Université
[8] Universidade de São Paulo,undefined
[9] Université Paris Saclay,undefined
[10] INSERM,undefined
[11] CNRS,undefined
[12] Institut de la Vision,undefined
来源
Journal of Human Genetics | 2020年 / 65卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:715 / 716
页数:1
相关论文
共 50 条
  • [41] Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
    Kemaladewi, Dwi U.
    Hoogaars, Willem M. H.
    van Heiningen, Sandra H.
    Terlouw, Samuel
    de Gorter, David J. J.
    den Dunnen, Johan T.
    van Ommen, Gert Jan B.
    Aartsma-Rus, Annemieke
    ten Dijke, Peter
    't Hoen, Peter A. C.
    BMC MEDICAL GENOMICS, 2011, 4
  • [42] PATTERNS OF EXON DELETIONS IN DUCHENNE AND BECKER MUSCULAR-DYSTROPHY
    READ, AP
    MOUNTFORD, RC
    FORREST, SM
    KENWRICK, SJ
    DAVIES, KE
    HARRIS, R
    HUMAN GENETICS, 1988, 80 (02) : 152 - 156
  • [43] EXON SKIPPING AND DUCHENNE MUSCULAR DYSTROPHY: A CLINICAL TRIAL UPDATE
    Wilton, Steve
    Fletcher, Sue
    JOURNAL OF GENE MEDICINE, 2013, 15 (8-9): : 330 - 330
  • [44] Next steps for the optimization of exon therapy for Duchenne muscular dystrophy
    Filonova, Galina
    Aartsma-Rus, Annemieke
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (02) : 133 - 143
  • [45] Current Outline of Exon Skipping Trials in Duchenne Muscular Dystrophy
    Eser, Gokce
    Topaloglu, Haluk
    GENES, 2022, 13 (07)
  • [46] Exon skipping: a first in class strategy for Duchenne muscular dystrophy
    Niks, Erik H.
    Aartsma-Rus, Annemieke
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (02) : 225 - 236
  • [47] Longitudinal management in Duchenne muscular dystrophy with exon 63 duplication
    Armytasari, Inggar
    Sutomo, Retno
    Triono, Agung
    BMJ CASE REPORTS, 2024, 17 (10)
  • [48] Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
    Dwi U Kemaladewi
    Willem MH Hoogaars
    Sandra H van Heiningen
    Samuel Terlouw
    David JJ de Gorter
    Johan T den Dunnen
    Gert Jan B van Ommen
    Annemieke Aartsma-Rus
    Peter ten Dijke
    Peter AC 't Hoen
    BMC Medical Genomics, 4
  • [49] Antisense-Mediated Exon Skipping for Duchenne Muscular Dystrophy
    Aartsma-Rus, Annemieke
    Heemskerk, Hans
    de Winter, Christa
    van Putten, Maaike
    Janson, Anneke
    Verschuuren, Jan
    den Dunnen, Johan
    van Deutekom, Judith
    van Ommen, Gert-Jan
    HUMAN GENE THERAPY, 2009, 20 (06) : 660 - 661
  • [50] The Status of Exon Skipping as a Therapeutic Approach to Duchenne Muscular Dystrophy
    Lu, Qi-Long
    Yokota, Toshifumi
    Takeda, Shin'ichi
    Garcia, Luis
    Muntoni, Francesco
    Partridge, Terence
    MOLECULAR THERAPY, 2011, 19 (01) : 9 - 15